• Extrawell Pharmaceutical extended its share placement deadline to November 20, 2026, from November 13 under a November 12 supplemental agreement.
• Placing agent uSmart Securities needs additional time to secure investors; all other placement terms remain unchanged.
• The placement price remains HKD 0.052 per share, a 1.89% discount to the November 12 closing price of HKD 0.053.
• That price represents a 2.36% premium to the preceding five trading days' average closing price of HKD 0.0508.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Extrawell Pharmaceutical Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261112-12410518), on November 12, 2026, and is solely responsible for the information contained therein.